Evidence from animal studies using GF, antibiotic-treated, depression models, and FMT mice has also demonstrated lower levels of BDNF in the hippocampus and cortex than in healthy controls (Clarke et al., 2013; Jang et al., 2021; Suda and Matsuda, 2022). This evidence concerns the gene BDNF and depressive symptom measurement.